For patients facing a rare disease, a genetic test isn’t the end of their story; it’s often just the beginning. A test result may point to a diagnosis, or it may reveal a genetic variant that we have ...
Parents’, Health Care Professionals’, and Scientists’ Experiences of a Precision Medicine Pilot Trial for Patients With High-Risk Childhood Cancer: A Qualitative Study To compare the classification of ...
The clinical interpretation of genetic testing results remains one of the most significant hurdles in effectively applying genomics in modern medicine. Errors in variant interpretation, whether false ...
BGI Genomics has successfully wrapped up its inaugural Whole Exome Sequencing (WES) Interpretation of Genetic Diseases Training Workshop for Southeast Asia, marking a significant milestone in ...
ROCKVILLE, Md. – Dec. 13, 2022 – The Association for Molecular Pathology (AMP), the premier global molecular diagnostic professional society, has published a report that was designed to assess ...
Identification of Genetic Risk Factors for Familial Urinary Bladder Cancer: An Exome Sequencing Study The use of the American College of Medical Genetics and Genomics and the Association for Molecular ...
As sequencing costs decrease, the volume of whole genome sequencing (WGS) and whole exome sequencing (WES) continues to rise. Sequencing is just the first step. To provide the best results requires ...
Understanding how the wealth of genetic variation in the human genome impacts on disease could potentially transform healthcare, but while we know the consequences of perhaps a handful of specific ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results